Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs SoundHound AI Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while SoundHound AI Inc trades at $4.43 (market cap $2.17B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 2.4× SoundHound AI Inc's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and SoundHound AI Inc for 24 Days on average.
| ORKA | SOUN | |
|---|---|---|
Market Cap | $5.18B | $2.17B |
Volume | 490,798 | 16,604,937 |
Sector | Health | Technology |
52-Week High | $113.08 | $21.40 |
52-Week Low | $26.19 | $4.53 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $4.31B | $1.98B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SoundHound AI (SOUN) trades at $4.88, down 1.81% on the day, with mixed technical signals showing bearish moving averages but bullish oscillators. The company demonstrates strong revenue growth with 2025 revenue of $168.92M and projected 2026 revenue of $203M, though it remains unprofitable with a -67.45% net income margin. Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch, while analyst consensus remains strongly bullish with a $9.33 price target.
SOUN presents a high-risk, high-reward opportunity with significant growth potential in voice AI markets but faces substantial execution risks. The stock offers 91% upside to analyst targets but requires careful monitoring of profitability improvements and competitive positioning. Key risks include persistent losses, integration challenges from acquisitions, and high valuation multiples despite negative earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
